The federal Food and Drug Administration has given its approval to the controversial drug flibanserin (Addyi), also known as “pink Viagra.” It is the first-ever drug aimed at increasing women’s libido. “[The] approval provides women distressed by their low sexual desire with an approved treatment option,” Janet Woodcock, MD, director of the FDA’s Center for… Continue reading FDA Approves Controversial “Viagra” for Women